ISRCTN65464501
Completed
Not Applicable
A multi-centre, phase II - III randomised clinical trial and observational study of defibrotide for the treatment of hepatic veno-occlusive disease after stem cell transplant
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites0 target enrollmentSeptember 12, 2003
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hepatic veno-occlusive disease (VOD)
- Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with diagnosis of VOD after a stem cell transplant.
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A randomised phase II/III multi-centre clinical trial of definitive chemo-radiaiton, with or without cetuximab, in carcinoma of the oesophagus - SCOPE 1in-operable carcinoma of the oesophagusMedDRA version: 8.1 Level: LLT Classification code 10030151 Term: Oesophageal cancerEUCTR2006-002241-37-GBVelindre NHS Trust
Completed
Phase 2
A trial evaluating cabazitaxel versus docetaxel rechallenge for the treatment of metastatic castrate refractory prostate cancer, previously treated with docetaxel at inception of primary hormone therapyProstate cancerCancerMalignant neoplasm of prostateISRCTN16465571niversity of Birmingham (UK)15
Active, not recruiting
Phase 1
CANTATA: Chemotherapy comparison in relapsing Prostate Cancer that has spreadEUCTR2012-003835-40-GBniversity of Birmingham15
Completed
Not Applicable
A Phase III randomised, double-blind, multicentre study to evaluate the safety and efficacy of 1592U89 (abacavir) in human immunodeficiency virus 1-infected patients with aquired immune deficiency syndrome dementia complexHIV-1 infection with AIDS dementiaInfections and InfestationsHIV, AIDSISRCTN53707238GlaxoSmithKline (UK)90
Recruiting
Phase 1
Study which tests 2 medications (SB27, Keytruda) to compare how effective, safe and well tolerated in a large number of metastatic non-squamous non-small cell lung cancer patientsCTIS2023-507448-36-00Samsung Bioepis Co. Ltd.616